Table 10. Summary of Disease Management ROI Values for Studies of Multiple Risk.
| Average Sample Size for Intervention | Average Evaluation Period (Years) | Average Per Participant Cost and Savings
|
Average ROI
|
|||
|---|---|---|---|---|---|---|
| Total Benefits/Costs | ||||||
| Study Design | Number | Cost | Savings | |||
| RCT | 2 | 96 | 2.0 | NA | $581.00 | 6.65 |
| CBA | 1 | 683 | 1.0 | $135.00 | 590.00 | 4.37 |
| Pre-Post | 1 | 188 | 1.3 | 324.00 | 3,520.68 | 10.87 |
| Total | 4 | 322 | 1.4 | 229.50 | 1,563.89 | 6.81 |
NOTES: ROI is return on investment. RCT is randomized clinical trials. CBA is controlled, before and after study design. NA is not applicable.
SOURCE: Cornell University Institute for Policy Studies, 2004.